NEW YORK, Feb. 18 (GenomeWeb News) - Cepheid reported higher revenues as well as losses for the fourth quarter of 2003 yesterday.
The company's revenues for the quarter totaled $5.3 million, up from $4.7 million during the same period last year.
R&D expenses increased slightly, to $4 million, from $3.8 million in the fourth quarter of 2002.
Cepheid's net loss climbed to $4.5 million, or $.13 per share, from $3.5 million, or $.11 per share, during the year-ago period.
As of Dec. 31, the company had cash and cash equivalents of $18.5 million.